Cambridge Life Sciences (CLS Diagnostics) has announced the launch of its latest venture, CLS Self Test, a new direct-to-consumer platform designed to bring high-quality diagnostic testing into the home.
The new website, https://clsselftest.com/, represents a significant step in CLS Diagnostics’ digital and commercial strategy—extending its long-standing expertise in clinical diagnostics into the rapidly growing self-testing market.
A Natural Evolution for a Trusted Diagnostics Provider
CLS Diagnostics has built its reputation on delivering reliable, high-performance diagnostic solutions across healthcare and laboratory environments.
The launch of CLS Self Test marks a natural evolution of this expertise, translating professional-grade diagnostics into accessible, user-friendly home testing kits.
The platform aims to empower individuals to take control of their health with confidence, privacy, and convenience.
Meeting the Demand for At-Home Healthcare
The move comes at a time when demand for at-home health solutions continues to accelerate. Advances in diagnostic technologies are enabling faster, more accessible disease detection and health monitoring outside traditional clinical settings.
By entering this space, CLS is positioning itself at the intersection of healthcare innovation and consumer empowerment.
CLS Self Test will offer a range of self-administered diagnostic kits, including rapid and easy-to-use testing devices designed to deliver reliable results with minimal complexity.
Backed by Established Infrastructure and Expertise
Unlike many emerging direct-to-consumer testing brands, CLS Self Test is not a standalone startup—it is part of and managed by CLS Diagnostics, providing a strong foundation of scientific credibility, regulatory compliance, and operational experience.
This backing ensures that the platform benefits from the same rigor and reliability expected in clinical environments.
Supporting a Broader Vision for Preventative Healthcare
The launch aligns with CLS Diagnostics’ broader mission to improve patient outcomes through innovation and accessibility. By decentralising diagnostics and bringing testing closer to the individual, CLS aims to support earlier detection, better health monitoring, and more proactive care.
Looking Ahead
CLS Self Test is expected to grow throughout 2026, with an expanding portfolio of products aimed at both individual consumers and wider health initiatives.
As healthcare continues to shift toward more personalised and preventative models, the introduction of trusted, clinically backed home testing solutions could play a key role in reshaping how people engage with their health.
With CLS Diagnostics’ expertise behind it, CLS Self Test is well positioned to become a leading name in the UK’s self-testing market.